MRI Results From the Optic Neuritis Treatment Trial

Update item information
Identifier 19910225_nanos_researchpres_05
Title MRI Results From the Optic Neuritis Treatment Trial
Creator Beck, Randy W
Subject Optic Neuritis Treatment Trial; Corticosteroid Treatment; Magnetic Resonance Imaging; Multiple Sclerosis
Description The Optic Neuritis Treatment Trial (ONTT), a multicenter study funded by the National Eye Institute, Is designed to determine the efficacy of corticosteroid treatment in optic neuritis. On entry into the ONTI, all patients undergo a standardized neurologic examination and magnetic resonance imaging (MRI) of the brain. On the basis of the clinical examination alone, by the Poser criteria the first 361 patients have been classified as definite multiple sclerosis in 5%, probable in 8%, possible in 20%, and no MS in 67%. Initial readings of the MRI scans at each clinic have classified the scans as abnormal in 59%: 93% abnormal in the definite MS group, 93% in the probable group, 66% In the possible group, and 49% in the noMS group. Each scan also is being graded by a central reading unit. The grading system and the results of these readings will be presented.
Relation is Part of NANOS 1991: Research Presentations
Contributor Primary Kupersmith, Mark J
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 1991-02-25
Type Text
Format application/pdf
Format Creation application/pdf
Source 1991 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2010. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6kq17sm
Setname ehsl_novel_nam
Date Created 2013-10-29
Date Modified 2021-05-06
ID 183074
Reference URL